Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas William LeBlanc

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Palliative Medicine|April 14, 2010
Grief, interruptedThomas William LeBlanc
Journal of Palliative Medicine|September 23, 2010
Young caregivers in the end-of-life setting: a population-based profile of an emerging groupCatherine Mary Burns, Thomas William LeBlanc, Amy Abernethy, et al.
Journal of Medical Economics|June 20, 2022
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United StatesAshley Tabah, Brenna L Brady, David Huggar, et al.
Journal of Palliative Medicine|February 9, 2018
The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid MalignanciesKathryn Elizabeth Hudson, Steven Paul Wolf, Gregory P Samsa, et al.
Journal of Managed Care & Specialty Pharmacy|June 16, 2022
Costs per patient achieving remission with venetoclax-based combinations in newly diagnosed patients with acute myeloid leukemia ineligible for intensive induction chemotherapyMichelle Choi, Jinlin Song, Cat N Bui, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Palliative Medicine|April 14, 2010
Grief, interruptedThomas William LeBlanc
Journal of Palliative Medicine|September 23, 2010
Young caregivers in the end-of-life setting: a population-based profile of an emerging groupCatherine Mary Burns, Thomas William LeBlanc, Amy Abernethy, et al.
Journal of Medical Economics|June 20, 2022
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United StatesAshley Tabah, Brenna L Brady, David Huggar, et al.
Journal of Palliative Medicine|February 9, 2018
The Surprise Question and Identification of Palliative Care Needs among Hospitalized Patients with Advanced Hematologic or Solid MalignanciesKathryn Elizabeth Hudson, Steven Paul Wolf, Gregory P Samsa, et al.
Journal of Managed Care & Specialty Pharmacy|June 16, 2022
Costs per patient achieving remission with venetoclax-based combinations in newly diagnosed patients with acute myeloid leukemia ineligible for intensive induction chemotherapyMichelle Choi, Jinlin Song, Cat N Bui, et al.
Pageof 1